EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Validated bioanalysis of oxylipins confirms specialized pro-resolving mediator formation in vitro and in vivo

Robert K Hofstetter, Markus Werner, Patrick Schädel, Mareike Wichmann-Costaganna, Katrin Fischer, Vera Bruggink, Katharina P L Meyer, Lukas Peltner, Kerstin Günther, Vivien Bachmann, Hannes Engelbrecht, Clemens Gutjahr und 6 weitere

Journal of Lipid Research · 2026

DOI: 10.1016/j.jlr.2026.101075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2026. Verfasst von Robert K Hofstetter und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Jena, Germany. Electronic address: rober…. Hauptthemen laut MEDLINE: Oxylipins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Marie Skłodowska-Curie Actions, Deutsche Forschungsgemeinschaft, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Specialized pro-resolving mediators (SPM) are di- or trihydroxylated polyunsaturated fatty acids with potent inflammation-resolving features. SPM typically occur at lower concentrations than classical pro-inflammatory eicosanoids, making their detection highly challenging. Thus, reporting of biological SPM levels has been discrepant and not always transparent, sparking uncertainty concerning the formation capacity for di- and especially for trihydroxylated SPM in vitro and in vivo. Here, we create common ground by providing a systematic and comprehensive assessment of SPM formation across a broad range of commonly employed in vitro, ex vivo, and in vivo matrices. For this purpose, a quantitative UHPLC-MS/MS method targeting 72 oxylipins (including 19 SPM) was validated in accordance with recommendations by the International Lipidomics Society. By including sample preparation (solid phase extraction) in all validation processes, a conservative lower limit of quantification (10-100 pg/ml matrix) was found to meet clearly defined criteria for signal/noise, accuracy, precision, selectivity, specificity, matrix effects, recovery, and carry-over for 19 SPM. Our results offer analytically defensible reference data to demonstrate (i) the absence of relevant SPM levels in stimulated whole blood and unstimulated cell models; (ii) only trace SPM formation in stimulated peripheral blood mononuclear cells, M1-macrophages, neutrophils, and platelet incubations; but (iii) significant SPM formation in stimulated M2a-macrophages and neutrophil/platelet co-incubations. In healthy C57BL/6JRj mice, SPM formation was low yet organ-specific, with relevant amounts of dihydroxylated SPM detected in spleen. Taken together, we demonstrate SPM formation to be robust, matrix- and stimulus-dependent, but confined to specific di- and trihydroxylated SPM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxylipinsSpecialized Pro-Resolving MediatorsAnimalsHumansMiceTandem Mass SpectrometryChromatography, High Pressure LiquidLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

arachidonic acidcell signalinginflammationlipidomicslipoxygenaseliquid chromatographymass spectrometryomega-3 fatty acidsoxidized lipidsvalidation

Substanzen

Oxylipins

Autor:innen und Institutionen

  • Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Jena, Germany. Electronic address: robert.klaus.hofstetter@uni-jena.de.
  • Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Jena, Germany.
  • Department of Pharmacology, Faculty of Pharmacy, Gazi University, Ankara, Turkey.
  • Mass Spectrometry Platform, Friedrich Schiller University Jena, Jena, Germany.
  • Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Jena, Germany; Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena, Jena, Germany.
  • Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Jena, Germany; Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena, Jena, Germany. Electron…

Förderung

  • H2020 Marie Skłodowska-Curie Actions
  • Deutsche Forschungsgemeinschaft
  • European Regional Development Fund
  • Carl-Zeiss-Stiftung
  • Thuringia Economic Development Bank
  • Horizon 2020 Framework Programme

Zitieren

APA

Hofstetter, R. K., Werner, M., Schädel, P., Wichmann-Costaganna, M., Fischer, K., Bruggink, V., Meyer, K. P. L., Peltner, L., Günther, K., Bachmann, V., Engelbrecht, H., Gutjahr, C., Perkowski, B., Griebel, G., Bal, N. B., Ueberschaar, N., Jordan, P. M., & Werz, O. (2026). Validated bioanalysis of oxylipins confirms specialized pro-resolving mediator formation in vitro and in vivo. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2026.101075

Vancouver

Hofstetter RK, Werner M, Schädel P, Wichmann-Costaganna M, Fischer K, Bruggink V, et al. Validated bioanalysis of oxylipins confirms specialized pro-resolving mediator formation in vitro and in vivo. Journal of Lipid Research. 2026. doi:10.1016/j.jlr.2026.101075

BibTeX
@article{Hofstetter2026,
  author = {Hofstetter, Robert K and Werner, Markus and Schädel, Patrick and Wichmann-Costaganna, Mareike and Fischer, Katrin and Bruggink, Vera and Meyer, Katharina P L and Peltner, Lukas and Günther, Kerstin and Bachmann, Vivien and Engelbrecht, Hannes and Gutjahr, Clemens and Perkowski, Bill and Griebel, Gregor and Bal, Nur Banu and Ueberschaar, Nico and Jordan, Paul M and Werz, Oliver},
  title = {Validated bioanalysis of oxylipins confirms specialized pro-resolving mediator formation in vitro and in vivo},
  journal = {Journal of Lipid Research},
  year = {2026},
  doi = {10.1016/j.jlr.2026.101075}
}
Kostenlos starten →